ADVISORY/Two Separate Studies Show Pneumococcal Vaccine is Extremely Effective for High Risk Native American Communities.Business Editors & Medical Writers ADVISORY...for Tuesday (May 1) NOTE TO EDITORS: Multimedia Assets Available With This Story Include Logos, Text News Releases, Video --(BUSINESS WIRE) Findings from two separate studies presented during the Pediatric Academic Societies conference, conclude that the new conjugated pneumococcal pneumococcal /pneu·mo·coc·cal/ (-kok´al) pertaining to or caused by pneumococci. vaccine, Prevnar, effectively protects Native American children from seven types of Streptococcus hemolytic streptococcus any streptococcus capable of hemolyzing erythrocytes, classified as a-hemolytic type, producing a zone of greenish discoloration much smaller than the clear zone produced by the ß-hemolytic type about the colony on blood agar; and the ß-hemolytic type, producing a clear zone of hemolysis immediately around the colony on blood agar. The most virulent streptococci belong to the latter group. pneumoniae bacteria. The studies, also show that the vaccine helps protect vaccinated children from becoming carriers of those seven types of bacteria. You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?2791 This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download video, audio, text, graphics, and photos. If you have any questions about the story, or about Newstream.com, please write to us at info@newstream.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion